Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease.

ABSTRACT:

Commentary

Sharing the burden of low-volume metastatic cancer between ICB and local treatments.

SUBMITTER: Lynch C 

PROVIDER: S-EPMC11458364 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature